-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QJ51jBMYQIUIetwuoX+HP9loierIssz20kSk9PWCyVKudgZDeRWW9mWwZYMgW/HG 01ywbKEXUV98UBpjy9SRxQ== 0001127602-10-009089.txt : 20100318 0001127602-10-009089.hdr.sgml : 20100318 20100318172035 ACCESSION NUMBER: 0001127602-10-009089 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100318 FILED AS OF DATE: 20100318 DATE AS OF CHANGE: 20100318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAHON PAUL A CENTRAL INDEX KEY: 0001231589 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 10692293 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2010-03-18 0001082554 UNITED THERAPEUTICS Corp UTHR 0001231589 MAHON PAUL A 1 EVP & General Counsel Common Stock 2010-03-18 4 M 0 4000 27.97 A 29500 D Common Stock 2010-03-18 4 S 0 4000 56.6495 D 25500 D Stock Options 27.97 2010-03-18 4 M 0 4000 0 D 2008-03-15 2017-03-15 Common Stock 4000 49000 D This exercise of stock options and the corresponding sale of shares were carried out pursuant to the 10b5-1 Plan adopted by the reporting person on May 6, 2009. /s/ Paul A. Mahon 2010-03-18 -----END PRIVACY-ENHANCED MESSAGE-----